Canada markets closed

GSK plc (GSK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
29.36-0.65 (-2.17%)
At close: 04:00PM EDT
29.65 +0.29 (+0.99%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close30.01
Open29.45
Bid29.45 x 1100
Ask29.65 x 2200
Day's Range29.09 - 29.63
52 Week Range29.09 - 46.97
Volume9,042,731
Avg. Volume6,519,685
Market Cap59.322B
Beta (5Y Monthly)0.26
PE Ratio (TTM)11.47
EPS (TTM)2.56
Earnings DateFeb 01, 2017 - Feb 06, 2017
Forward Dividend & Yield2.48 (8.46%)
Ex-Dividend DateMay 19, 2022
1y Target Est54.29
  • Sky News

    GSK poaches Burberry CFO to create all-female top team

    GSK, the FTSE-100 pharmaceuticals giant, has poached Burberry Group's finance chief to create a rare all-female executive leadership team in London's blue-chip share index. Sky News has learnt that GSK could announce as soon as Monday morning that it has recruited Julie Brown to replace Iain Mackay, who has served as its chief financial officer since 2019. The appointment of Ms Brown comes during a period of seismic change for GSK, which demerged its consumer healthcare business - now called Haleon - in a £30bn deal in July.

  • Reuters

    UPDATE 1-GSK poaches Burberry CFO Julie Brown to create all-female top team - Sky News

    British drugmaker GSK plc has poached Burberry Group's finance chief to create a rare all-female executive leadership team, Sky News reported on Saturday. GSK could announce as soon as Monday morning that it has recruited Julie Brown to replace Iain Mackay, who has served as its chief financial officer since 2019, the report added. On Friday, Burberry announced that its finance chief Julie Brown will step down in April 2023 after more than five years in the role.

  • Zacks

    Spero (SPRO) Skyrockets 168% on Licensing Deal With GSK

    The exclusive licensing agreement with GSK will fund Spero's (SPRO) existing operations and extend its current cash runway beyond 2024.